Early detection and prompt treatment of psychosis is of the utmost importance. The great variability in clinical onset, illness course, and response to pharmacological and psychosocial treatment is in great part gender-related. Our aim has been to review narratively the literature focusing on gender related differences in the psychoses, i.e., schizophrenia spectrum disorders. We searched the PubMed/Medline, Scopus, Embase, and ScienceDirect databases on 31 July 2021, focusing on recent research regarding sex differences in early psychosis. Although women, compared to men, tend to have better overall functioning at psychotic symptom onset, they often present with more mood symptoms, may undergo misdiagnosis and delay in treatment and are at a higher risk for antipsychotic drug-induced metabolic and endocrine-induced side effects. Furthermore, women with schizophrenia spectrum disorders have more than double the odds of having physical comorbidities than men. Tailored treatment plans delivered by healthcare services should consider gender differences in patients with a diagnosis of psychosis, with a particular attention to early phases of disease in the context of the staging model of psychosis onset.

Mazza, M., Caroppo, E., De Berardis, D., Marano, G., Avallone, C., Kotzalidis, G. D., Janiri, D., Moccia, L., Simonetti, A., Conte, E., Martinotti, G., Janiri, L., Sani, G., Psychosis in women: Time for personalized treatment, <<JOURNAL OF PERSONALIZED MEDICINE>>, 2021; 11 (12): 1279-N/A. [doi:10.3390/jpm11121279] [http://hdl.handle.net/10807/202505]

Psychosis in women: Time for personalized treatment

Mazza, M.;Caroppo, E.;Avallone, C.;Moccia, L.;Simonetti, A.;Conte, E.;Martinotti, G.;Janiri, L.;Sani, G.
2021

Abstract

Early detection and prompt treatment of psychosis is of the utmost importance. The great variability in clinical onset, illness course, and response to pharmacological and psychosocial treatment is in great part gender-related. Our aim has been to review narratively the literature focusing on gender related differences in the psychoses, i.e., schizophrenia spectrum disorders. We searched the PubMed/Medline, Scopus, Embase, and ScienceDirect databases on 31 July 2021, focusing on recent research regarding sex differences in early psychosis. Although women, compared to men, tend to have better overall functioning at psychotic symptom onset, they often present with more mood symptoms, may undergo misdiagnosis and delay in treatment and are at a higher risk for antipsychotic drug-induced metabolic and endocrine-induced side effects. Furthermore, women with schizophrenia spectrum disorders have more than double the odds of having physical comorbidities than men. Tailored treatment plans delivered by healthcare services should consider gender differences in patients with a diagnosis of psychosis, with a particular attention to early phases of disease in the context of the staging model of psychosis onset.
Inglese
Mazza, M., Caroppo, E., De Berardis, D., Marano, G., Avallone, C., Kotzalidis, G. D., Janiri, D., Moccia, L., Simonetti, A., Conte, E., Martinotti, G., Janiri, L., Sani, G., Psychosis in women: Time for personalized treatment, <<JOURNAL OF PERSONALIZED MEDICINE>>, 2021; 11 (12): 1279-N/A. [doi:10.3390/jpm11121279] [http://hdl.handle.net/10807/202505]
File in questo prodotto:
File Dimensione Formato  
jpm-11-01279_psychosis in women.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 3.6 MB
Formato Adobe PDF
3.6 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/202505
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact